PHARMACEUTICAL company Adcock Ingram has completed the acquisition of a 65,59% stake in a leading Ghanaian drugs company Ayrton. The acquisition was made through wholly-owned subsidiary, Adcock Ingram International. CEO Jonathan Louw said that following this acquisition, Adcock planned to launch a new portfolio of products into Ghana and West Africa. He said Ayrton had huge potential and its product range was similar to that produced in SA by Adcock so this was a perfect strategic fit for both businesses.

Business Day, 14 April 2010